Q14: Analytical Procedure Development

Q14: Analytical Procedure Development

Analytical procedure development is the process of designing and optimizing methods to accurately and precisely measure the active pharmaceutical ingredient (API), excipients, impurities, and degradation products in a drug substance or drug product. The goal is to...
Case Study: OOS Investigation – Tablet Dissolution

Case Study: OOS Investigation – Tablet Dissolution

📝 Case Study: OOS Investigation – Tablet Dissolution 📍 Background A marketed immediate-release tablet showed dissolution failure during routine quality control testing. Specification: NLT (Not Less Than) 80% drug release in 30 minutes. Observed result: 60–65% release...
4 Tips to Reduce 483 Observations

4 Tips to Reduce 483 Observations

4 Tips to Reduce 483 Observations The FDA issues Form 483 to highlight potential GMP violations observed during inspections. Minimizing these observations requires a proactive approach to compliance and quality culture. 1. Strengthen Documentation Practices Ensure...

Hello
Chat now via Whatsapp